Cargando…
Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential
Small cell lung cancer (SCLC) is a highly lethal subtype of lung cancer that has seen few therapeutic advances, despite ongoing concerted efforts. Immunotherapy has been an effective option in other carcinogen-related cancers and has shown modest activity in SCLC. Monotherapy with the anti-PD-1 anti...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822836/ https://www.ncbi.nlm.nih.gov/pubmed/31209697 http://dx.doi.org/10.1007/s12325-019-01008-2 |